Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CHESS-SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease: an International Multicenter Study (CHESS2102)

NCT04975477 is registered in ClinicalTrials.gov with Hepatopancreatobiliary Surgery Institute of Gansu Province as lead sponsor.

NCT NCT04975477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04975477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CHESS-SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease: an International Multicenter Study (CHESS2102)
Lead sponsor
Hepatopancreatobiliary Surgery Institute of Gansu Province
Phase
Observational
Overall status
Unknown status
Start date
July 16, 2021
Completion date
August 16, 2021
Enrollment
1,000 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

compensated advanced chronic liver disease